Amphiregulin (AREG), a principal ligand of the epidermal growth factor receptor (EGFR, also known as ErbB1), plays a critical role in colorectal carcinoma by driving tumor cell proliferation, survival and resistance to therapy. This evidence concerns the gene AREG and colorectal carcinoma.